Comparison of Deep Brain Stimulation and Responsive Neurostimulation Wound Complication Rates and Risk Factors: A Single-Center Retrospective Study
Stereotactic and Functional Neurosurgery · 2025
DOI: 10.1159/000545146 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Stereotactic and Functional Neurosurgery, 2025. Verfasst von Eric Bayman und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Drug Resistant Epilepsy, Postoperative Complications, Surgical Wound Infection. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Introduction
Deep brain stimulation (DBS) and responsive neural stimulation (RNS) are effective for patients with pharmacoresistant epilepsy. Similar outcomes and increasingly convergent indications mean the choice of device may come down to other factors. Common to implanted therapeutic devices, wound-associated adverse outcomes are among the more common complications for these two procedures. However, there have been limited studies evaluating the differences in wound complication rates between DBS and RNS, despite the procedural differences for implantation for the two devices. Our objective was to analyze the differences in wound complication rates between patients who received DBS and RNS devices at the University of Colorado Hospital between 2016 and 2023.
Methods
All DBS and RNS surgeries performed from 2016 to 2023 for two surgeons at the University of Colorado Hospital were retrospectively reviewed. Wound complications included infection, hardware protrusion, or wound erosion requiring surgical washout, explant, or replacement. Risk factors evaluated included age, sex, diabetes, body mass index, and immunocompromised status. Incidence of complications and risk factors were evaluated and compared using a chi-squared and Mann-Whitney U test. The relationship between selected risk factors and the probability of wound complication was evaluated using a binomial logistic regression.
Results
A total of 297 patients underwent DBS (n = 234, n = 218 for movement disorders, n = 16 for epilepsy) and RNS (n = 63) implantation. The DBS group had higher median age at the time of surgery compared to the RNS group (65 vs. 37, p < 0.001), and no other significant differences in group characteristics were noted. Wound complication incidence was greater in the RNS group compared to DBS (12.7% vs. 4.3%, p < 0.001). No other risk factors were noted to contribute to wound complication rate.
Conclusion
Wound complication incidence was greater in RNS patients compared to DBS patients. Differences in age, sex, body mass index, and immunocompromised status were not associated with increased wound complication risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Zitieren
APA
Bayman, E., Anigbogu, C., Razmara, A., Ojemann, S. G., Thompson, J. A., & Kramer, D. R. (2025). Comparison of Deep Brain Stimulation and Responsive Neurostimulation Wound Complication Rates and Risk Factors: A Single-Center Retrospective Study. Stereotactic and Functional Neurosurgery. https://doi.org/10.1159/000545146
Vancouver
Bayman E, Anigbogu C, Razmara A, Ojemann SG, Thompson JA, Kramer DR. Comparison of Deep Brain Stimulation and Responsive Neurostimulation Wound Complication Rates and Risk Factors: A Single-Center Retrospective Study. Stereotactic and Functional Neurosurgery. 2025. doi:10.1159/000545146
BibTeX
@article{Bayman2025,
author = {Bayman, Eric and Anigbogu, Chiagoziem and Razmara, Ashkaun and Ojemann, Steven G and Thompson, John A and Kramer, Daniel R},
title = {Comparison of Deep Brain Stimulation and Responsive Neurostimulation Wound Complication Rates and Risk Factors: A Single-Center Retrospective Study},
journal = {Stereotactic and Functional Neurosurgery},
year = {2025},
doi = {10.1159/000545146}
}
EUVIMED